Staar Surgical (STAA) Cost of Revenue (2010 - 2026)

Staar Surgical (STAA) has reported Cost of Revenue for 17 consecutive years, with $23.8 million the latest figure, recorded in Q3 2026.

• For the quarter ending Q3 2026, Cost of Revenue rose 106.65% year-over-year to $23.8 million; the trailing twelve-month figure through Jul 2026 stood at $79.4 million (up 25.0% YoY), and the FY2026 full-year result was $57.0 million, down 23.27% from the prior year.
• Cost of Revenue eased to $23.8 million in Q3 2026 per STAA's latest filing, from $24.7 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $24.7 million in Q2 2026 and bottomed at $11.5 million in Q2 2025.
• Historically, Cost of Revenue has averaged $17.3 million across 5 years, with a median of $16.5 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Cost of Revenue plunged 44.05% in 2025, then jumped 106.65% in 2026.
• Over 5 years, Cost of Revenue stood at $14.3 million in 2022, then increased by 9.04% to $15.5 million in 2023, then advanced by 11.28% to $17.3 million in 2024, then slipped by 2.57% to $16.9 million in 2025, then surged by 41.24% to $23.8 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $23.8 million, $24.7 million, and $14.1 million for Q3 2026, Q2 2026, and Q1 2026 respectively.